Evidence map›Paper›PMID 35282003›Full record

ReviewTherapeutic advances in ophthalmology

Comprehensive overview of IRVAN syndrome: a structured review of Case Reports and Case Series.

Hashim Ali Khan, Qaim Ali Khan, Muhammad Aamir Shahzad, Muhammad Amer Awan, Naeemullah Khan, Smaha Jahangir, Fiza Shaheen, Kamran Wali, Julie Rodman, Jozeph Pizzimenti and 1 more

Open access · diamondAbstract readReview
In one paragraph

Review in Therapeutic advances in ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 3 countries.

Hashim Ali KhanDepartment of Ophthalmology, SEHHAT Foundation Hospital, Danyor, Gilgit 15100, Pakistan.ORCID https://orcid.org/0000-0002-6538-2033
Qaim Ali KhanOphthalmology Department, Agha Khan Health Services, Gilgit, Pakistan.
Muhammad Aamir ShahzadOphthalmology Department, Aziz Fatimah Medical & Dental College, Faisalabad, Pakistan.
Muhammad Amer AwanOphthalmology Department, Shifa International Hospital and Shifa College of Medicine, Islamabad, Pakistan.
Naeemullah KhanAdvance Eye Care, Gilgit, Pakistan.
Smaha JahangirSchool of Optometry, The University of Faisalabad, Faisalabad, Pakistan.
Fiza ShaheenAl-Shifa Trust Eye Hospital, Rawalpindi, Pakistan.
Kamran WaliAdvance Eye Care, Gilgit, Pakistan.
Julie RodmanBroward Eye Care Institute, Nova Southeastern University, Fort Lauderdale, FL, USA.
Jozeph PizzimentiRosenberg School of Optometry, University of the Incarnate Word, San Antonio, TX, USA.
Ali Osman SaatciDepartment of Ophthalmology, Dokuz Eylul University, İzmir, Turkey.ORCID https://orcid.org/0000-0001-6848-7239
Aga Khan Development Network · PKDokuz Eylül University · TRHoly Family Hospital · PKNova Southeastern University · USPunjab Medical College · PKShifa International Hospital · PKUniversity of Faisalabad · PKUniversity of the Incarnate Word · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome is a rare spectrum of retinal vasculitis, aneurysms, and neuroretinitis affecting young individuals in their third decade. Most of our current knowledge is based on case reports, case series, and a handful of collaborative studies. There is much diversity in treatment approaches and outcomes in the reported literature. We have aggregated published case reports and case series into quantitative and narrative synthesis to draw evidence-based conclusions toward clinical features, atypical and rare findings, systemic associations, disease course, and treatment outcomes. The analysis suggested the disease mostly affects young individuals with a female predilection. Anterior chamber and vitreous inflammation are common than previously believed. The most prevalent pattern of retinal vasculitis in IRVAN eyes is mixed vasculitis, followed by arteritis and phlebitis. Most eyes at the time of presentation have capillary nonperfusion and require treatment. Most eyes retain good visual acuity; however, treatment is required to maintain visual function. Intravitreal antivascular endothelial growth factors administered as an adjunct to retinal laser photocoagulation are more likely to improve visual outcomes. Besides, we have discussed the different hypotheses on the etiopathogenesis of the disease and stronger evidence suggests an inflammatory origin of the disease.

Indexed as

anti-VEGFIRVAN syndromeneuroretinitisposterior uveitisretinal aneurysmsretinal vasculitis

Identifiers

PMID35282003
PMCPMC8905214
OpenAlexW4206061535

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.